These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20436301)

  • 41. Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells.
    Menendez D; Lowe JM; Snipe J; Resnick MA
    Oncotarget; 2016 Sep; 7(38):61630-61642. PubMed ID: 27533082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
    Orgad S; Dimant H; Dor-On E; Azriel-Rosenfeld R; Benhar I; Solomon B
    J Immunother; 2010; 33(2):146-54. PubMed ID: 20139776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
    Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
    Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
    Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
    Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis.
    Fiorini C; Menegazzi M; Padroni C; Dando I; Dalla Pozza E; Gregorelli A; Costanzo C; Palmieri M; Donadelli M
    Apoptosis; 2013 Mar; 18(3):337-46. PubMed ID: 23238993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
    Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H
    Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hsp90 is essential for restoring cellular functions of temperature-sensitive p53 mutant protein but not for stabilization and activation of wild-type p53: implications for cancer therapy.
    Müller P; Ceskova P; Vojtesek B
    J Biol Chem; 2005 Feb; 280(8):6682-91. PubMed ID: 15613472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restoring p53-dependent tumor suppression.
    Wang W; Rastinejad F; El-Deiry WS
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S55-63. PubMed ID: 14508081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
    Yang L; Song T; Cheng Q; Chen L; Chen J
    Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy.
    Liu Y; Wang X; Wang G; Yang Y; Yuan Y; Ouyang L
    Eur J Med Chem; 2019 Aug; 176():92-104. PubMed ID: 31100649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a tumor-derived p53 mutant with novel transactivating selectivity.
    Pan Y; Haines DS
    Oncogene; 2000 Jun; 19(27):3095-100. PubMed ID: 10871862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.
    Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC
    Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
    Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
    Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rescue of mutant p53 transcription function by ellipticine.
    Peng Y; Li C; Chen L; Sebti S; Chen J
    Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation.
    Mahdi T; Alcalay D; Cognard C; Tanzer J; Kitzis A
    Biol Cell; 1998 Dec; 90(9):615-27. PubMed ID: 10085538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.